Feasibility Assessment of the Let’s Walk Programme (CAMINEM): Exercise Training and Health Promotion in Primary Health-Care Settings by Mas Alòs, Sebastià et al.




Feasibility Assessment of the Let’s Walk Programme
(CAMINEM): Exercise Training and Health Promotion in
Primary Health-Care Settings





Planas-Anzano, A.; Peirau-Terés, X.;
Real-Gatius, J.; Galindo-Ortego, G.
Feasibility Assessment of the Let’s
Walk Programme (CAMINEM):
Exercise Training and Health
Promotion in Primary Health-Care
Settings. Int. J. Environ. Res. Public
Health 2021, 18, 3192. https://
doi.org/10.3390/ijerph18063192
Academic Editor: Paul Tchounwou
Received: 12 February 2021
Accepted: 17 March 2021
Published: 19 March 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 National Institute of Physical Education of Catalonia (INEFC), Lleida Campus, E-25192 Catalonia, Spain;
aplanas@gencat.cat (A.P.-A.); xpeirau@gencat.cat (X.P.-T.)
2 Grup de Recerca de Moviment Humà, University of Lleida (UdL), E-25192 Catalonia, Spain
3 School of Medicine and Health Sciences, Universitat Internacional de Catalunya,
E-08195 Sant Cugat del Vallés, Spain; jreal@idiapjgol.info
4 Unitat de Suport a la Recerca Lleida—Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi
Gol (IDIAP Jordi Gol), Lleida, E-25007 Catalonia, Spain
5 Catalan Institute of Health, Lleida, E-25002 Catalonia, Spain; ggalindo.lleida.ics@gencat.cat
* Correspondence: smasalos@gencat.cat; Tel.: +34-973-272022
Abstract: Exercise is related to many individual health outcomes but impact evaluations of exercise
programmes are seldom conducted. The purpose of the study is to evaluate the feasibility of an exer-
cise prescription intervention in primary health-care settings (CAMINEM Programme) located in two
socially disadvantaged neighbourhoods. The CAMINEM was a pragmatic-driven intervention with
opportunistic recruitment. It followed the 5As framework for health promotion and also the exercise
training principles. Feasibility was evaluated using the RE-AIM framework (Reach, Effectiveness,
Adoption, Implementation, and Maintenance). Patients with non-communicable chronic diseases
participated in a 12-month home-based moderate-intensity exercise program, counselled by exercise
physiologists. Participants were grouped according to their physical activity behaviour at baseline
and 6-month adherence. CAMINEM reached 1.49% (n = 229) of the eligible population (N = 15,374)
and included a final sample of 178. Health outcomes for adhered participants followed positive
patterns. Non-adhered participants visited their practitioner more compared to adhered participants.
Thirty-three practitioners (40%) referred patients. Nurses referred four times more than physicians
(81% and 19% respectively). The delivery of exercise prescriptions proved to be easy to complete and
record by participants as well as easy to monitor and adjust by the exercise physiologists. One out of
four participants adhered during the 12-month intervention. This intervention has been feasible in
primary care in Catalonia, Spain, to safely prescribe home-based exercise for several conditions.
Keywords: physical activity; RE-AIM; HEPA; community-based participatory research; adherence;
health outcomes; exercise prescription; implementation science; public health; sedentary behavior
1. Introduction
Physical inactivity was identified as the fourth leading risk factor for global mor-
tality [1] and trend data showed limited improvement between 2001 and 2016 [2] and
between 2007 and 2017 [3]. Consequently, member states of the WHO agreed to achieve a
10% relative reduction in the prevalence of physical inactivity by 2050, as one of the global
targets for the prevention and treatment of non-communicable diseases [4]. They also
suggested that some differences in physical activity levels within and between countries
can be explained by inequities in opportunities to be physically active, as was identified
by Bauman et al. [5]. Even low levels of physical activity may reduce morbidity, all-cause
mortality, and length life expectancy [6]. Accordingly, physical activity promotion is al-
ready issued in clinical guidelines, even excluding physical activity-specific guidelines [7].
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Health-enhancing physical activity (HEPA) promotion includes primary health-care (PHC)
settings because they reach a substantial number of people who overall, are more inactive
and may benefit more [8,9]. In Spain, roughly 46% of the population are advised to walk as
HEPA promotion [10].
Practitioners need systematic work to achieve habit change such as sedentary be-
haviour [11]. Written physical activity prescriptions have been feasible for practitioners
and patients in health-care settings [8,12,13]. However, Spanish interventions of HEPA are
seldom detailed and reported [10]. Catalan general practitioners rarely see HEPA promo-
tion as a priority in 5-min consultations [14]. Moreover, 55% of the physicians who already
promote HEPA consider there to be not enough time. Recently, Martínez–Gómez et al. [10]
suggested that Spanish physicians may tailor counselling and provide written directions of
HEPA, but there is a challenge to structuring this counselling (e.g., frequency and duration
of walking) given time constraints and lack of staff training. Additionally, pre-exercise
medical clearance is generally unnecessary [15], especially when the intensity of the activity
is planned to be light to moderate [16].
Feasibility of the approaches is not universal; policies and legal frameworks differ
between countries, and even between regions within the same country (e.g., Spain). The
Reach, Efficacy/Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM)
framework [17] was first designed to estimate the public health impact of an intervention
and it has been accepted to target the feasibility of HEPA interventions in community
settings, such as PHC centres [18,19].
Recently, the European Commission, through the Public Health Agency, made a call
for countries to transfer the Swedish Physical Activity on Prescription Model to other
European regions, and the EUPAP Project (www.eupap.org, accessed on 1 February 2021)
is actually ongoing and aiming to implement the Swedish Physical Activity on Prescrip-
tion Model into nine other countries: Catalonia (Spain), Denmark, Flanders (Belgium),
Germany, Italy, Lithuania, Malta, Portugal, and Romania [20]. The health sector is the
gate for citizens to receive HEPA prescriptions, mostly primary healthcare settings, and
the first option is that the physical activity is performed outside the healthcare setting.
The core components of the Swedish model to be adapted by the EUPAP Project include:
individualised patient-centered counselling, written prescription, evidence-based physical
activity recommendations, follow-up, and collaboration with activity organisers [21].
The overall aim of this pragmatic study was to evaluate the feasibility (i.e., external
validity) of the CAMINEM (Let’s Walk) Programme as an exercise-on-prescription, in-
terdisciplinary approach for 12 months in two socially disadvantaged neighbourhoods.
The specific aims were to (i) determine if CAMINEM reached the citizens with chronic
health conditions that may benefit from exercising (Reach), (ii) assess clinical and quality-
of-life outcomes and the use of health services (Effects), (iii) determine the adoption
of CAMINEM by the practitioners (Adoption), (iv) evaluate participants’ retention and
compliance (Implementation), and (v) describe if the practitioners prescribe exercise post-
intervention (Maintenance).
2. Materials and Methods
The study was a pragmatic-driven intervention with opportunistic recruitment by
general practitioners (GPs) or community nurses during 18 months–that is, regular patients
aged 18 and above who visited their GP or community nurse may be invited. Participants
received an exercise written prescription and were followed-up by an exercise physiologist
for twelve months before being discharged. The rationale and design of the CAMINEM
programme, including detailed procedures (referral, first face-to-face contact, follow-up,
discharge) is published elsewhere [22,23]. Supplementary material Figures S1–S4 and Table
S5 illustrates them.
There were no fixed inclusion criteria for the patients but practitioners focused on
diseases in which exercise is known to be beneficial (i.e., overweight/obesity, hypertension,
diabetes mellitus, dyslipidaemia, musculoskeletal pain, respiratory diseases, and minor
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mental health problems). Exclusion criteria were overt cardiovascular disease, uncon-
trolled hypertension, uncontrolled insulin-dependent diabetes, or other conditions that
prevented participation in a walking programme determined by the practitioner or the
exercise physiologist.
The settings of intervention were selected following a convenience sampling; that is,
two primary health-care settings in the city of Lleida that offered health services to the two
highest socially disadvantaged neighbourhoods, out of a total of seven primary health-care
settings. The reason for this is that Catalan health policies encourage health promotion in
such neighbourhoods, and it has eventually been found positive by WHO [24,25]. All GPs
and community nurses working at least 3 months in any of these two settings were invited
to participate by referring patients to the CAMINEM Programme.
The CAMINEM Programme provides a set of tools for practitioners to individualise
exercise prescriptions: validated urban routes to monitor HEPA [26], a short questionnaire
to asses physical activity level (ClassAF) [27], and a prescription form/logbook to monitor
adherence (i.e., exercising following the prescriptions). This pragmatic study included
the participation of a non-staffed exercise physiologist who counselled the participants
previously referred by their GP or nurse. Exercise counselling relied on the 5As framework
(Ask, Advise, Agree, Assist, Arrange) for health promotion [28] and the exercise training
principles. Exercise periodization followed the health-oriented guidelines from the Ameri-
can College of Sports Medicine [29] and the Catalan exercise prescription handbook [27].
The conditioning period goal (up to two months) was to ensure that participants followed
the WHO recommendations on physical activity for health for adults and older adults with
a minimum of 150 minutes weekly of moderate-intensity aerobic physical activity [1]. The
improvement period (two to six months) focused on increasing the total amount of exercise
volume (first frequency, then duration), and on keeping adherence. The maintenance
period (six to 12 months) aimed to maintain or increase exercise volume.
The exercise was unsupervised, individually based, moderate-intensity, continuous,
and aerobic; that is, walking. Individualization of prescriptions was set during the first
meeting with the exercise physiologist who underwent a motivational interview with each
participant. Together they set goals, chose the specific urban route, set the frequency and
duration of each walk, and scheduled the next follow-up meeting. The exercise physiologist
delivered the written exercise prescription and then explained how to self-control the
intensity of exercising using the Talk Test [30], as it has recently been suggested [31].
Follow-up meetings were for monitoring the compliance (adherence), giving advice to
overcome possible barriers, and discussing the exercise prescription to finally deliver a new
update on the written exercise prescription. Participants completed the full intervention
after 12 months, were discharged and encouraged to keep an active lifestyle, and monitor
their HEPA. Specific criteria for decision making are shown in Supplementary Material S5.
For the feasibility study we evaluated the five dimensions of the RE-AIM frame-
work [17] (see Table 1).
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Table 1. Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) Dimensions and their evaluative
questions. Based on Glasgow [32] and Estabrooks & Gyurcsik [33].
RE-AIM Dimension Evaluative Questions
Reach
(Individual level)




What impact did the intervention have on all participants who began the program,
on process intermediate and primary outcomes, and on both positive and negative
(unintended) outcomes including quality of life?
Adoption
(Setting level)
What percentage of settings and intervention agents will participate and how
representative are they?
Implementation
(Both setting or agent and individual level)
To what extent are the various intervention components delivered as intended,
especially when conducted by regular staff in applied settings?To what extent did
the participants receive and enacts the intervention components?
Maintenance
(Both setting and individual level)
To what extent are different intervention components continued or
institutionalized?
What are the long-term effects?
Reach referred the participation rate among eligible patients, taken from the health
provider medical records. Reasons for exclusion and dropout were collected in a Microsoft®
Access database created ad hoc.
Effects outcomes included clinical health, health-related quality of life (HRQOL), and
health services use. Clinical health outcomes (BMI, waist circumference, blood pressure,
resting heart rate, and biochemical compounds from blood samples [glucose, triglyc-
erides, glycated haemoglobin, HDL, LDL, and total cholesterol]) were collected before
(M1 pre-test), during (M2 6 months), and after (M3 post-test) the intervention by nurses
during their regular routine unless no data had been recorded within 6 months prior
to the referral. To measure HRQOL we used the Short Form 12 Health Survey version
2 (SF-12v2) in Catalan [34], and a simple question comparing self-perceived well-being
in two separate moments: ‘What do you think about your overall health, is it better,
worse, or the same as the day you started the CAMINEM?’. Health services use (i.e.,
the number of monthly visits with practitioners) data were obtained from the health
provider database, and was measured as a ratio of number of the visits to the physician
or nurse per month. We focused on the effects and not efficacy/effectiveness because
efficacy trials can be obtained under optimal conditions (e.g., RCT design) (Flay, 1986,
as cited in Estabrooks & Gyurcsik, 2003, p. 43) and effectiveness is ”the extent to which the
intended effect or benefits that could be achieved under optimal conditions are achieved
in practice” [35]. Since none of the previous had been done before, we relied on the
health effects.
Adoption referred as the participation rate among the total number of potential
participant agents (i.e., staffed GPs and nurses).
Implementation referred to participants’ adherence, which included (i) retention days,
(ii) attendance at follow-up meetings, and (iii) exercise compliance. For participants to be
compliant they had to complete more than 50% of the prescribed exercise sessions. The
6-month assessment was considered a critical breakpoint since most dropouts occur within
that time when starting a physical activity program [36]. Participants included longer than
six months were considered as retained but not necessarily adhered to the intervention.
They may attend follow-up meetings but may not exercise as intended (e.g., less frequently).
Safety was measured as the number of adverse events reported by either participants or
practitioners while exercising.
Maintenance data at the individual level were to be assessed 3-months post-intervention
by regards of clinical, HRQOL and physical activity level. Assesments at 6- and 12-months
post-intervention were set as the number of prescriptions delivered by the practitioners.
Unfortunately, these assessments were not done due to a high amount of missing data that
were supposed to be collected by regular practitioners.
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Variables were analysed between 4 cohort groups distributed according to their basal
physical activity level (AC/IN, previously active/inactive) and their adherence for a
minimum of 6 months (AD/NA, adhered/non adhered). Dropout participants were evalu-
ated as intention-to-treat. Categorical variables are presented as percentages. Pearson’s
chi-squared (χ2) tests were used to determine differences between groups. Continuous
variables are presented as the mean value and standard deviation (SD). Statistical dif-
ferences were assessed by analyses of variance (ANOVA) by time in relation to the four
groups using the Schefée test, a contrast coefficient test when comparing two subgroups
out of all four, and the t-test when comparing two groups only (i.e., effects for the adhered
groups only). Normally distributed variables were tested according the Shapiro–Wilk test
for samples lower than 30, and the Kolmogorov–Smirnov test if higher than 30. Analyses
pre- and post-intervention were done if the sample was higher than five. Continuous
variables that statistically differed between groups at baseline (i.e., confounding factors)
were used as covariates. ANOVA was used for variables following normal distribution.
Non-parametric tests were applied for variables that were not normally distributed: the
Mann–Whitney U test between groups, the Wilcoxon signed-rank test (Wilcoxon’s Z) for
two measurements within groups, and the Kendall’s coefficient of concordance (Kendall’s
W) for three measurements within groups. Mean differences between moments were
shown as total difference and the percentage of difference. PASW statistics (release 18.0.0)
was used for data treatment and for all analyses. Statistical significance was set at p < 0.05
with 95% of confidence intervals.
The Clinical Investigation Ethics Committee of the IDIAP, Jordi Gol, Barcelona, ap-
proved this study, and it followed the ethical principles of the Declaration of Helsinki.
Participants gave their verbal consent for referral and signed an informed consent before
inclusion. Clinical data collection was part of the ordinary healthcare practice and written
permission to use these data was obtained from the healthcare provider. The exercise




Figure 1 shows the flowchart of the 178 participants included in the study (mean age
58.1 ± 12.2, women n = 115), the number of retained participants (i.e., not dropout even
without being compliant with the exercise prescriptions), participants who adhered to the
program (i.e., were compliant with the prescriptions), and the reasons for dropout. Note
that 19 participants were still adhering to the intervention by the time this feasibility study
ended; that is, they did not complete the minimum of 6-month adherence but did not drop
out either.
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Figure 1. Flowchart of he participants included i CAMINEM intervention. * Patients may have more than one
condition. The CAMINEM Program e addressed patients fro t o primary health-care settings in socially disadvantaged
neighbourhoods. All practitioners (physicians and community nurses) were invited to participate. Patients to be included
had to be visited by their practitioner during a regular visit, accepted their oral invitation, being referred to the exercise
physiologist and finally sign the informed consent. Retention refers to not drop out while adherence shows fulfillment of
the exercise prescription.
Int. J. Environ. Res. Public Health 2021, 18, 3192 7 of 18
The most common reasons for referral were dyslipidaemia and diabetes mellitus in
men, and musculoskeletal diseases and mental health conditions in women. Patients with
high blood pressure were referred almost exclusively by nurses: 48% of patients suffering
from it were referred by nurses, compared to 3% by GPs. Practitioners referred from
one healthcare setting (PHC_A) mostly referred patients with one (45.5%) or two (31.2%)
conditions, while practitioners from the other healthcare setting (PHC_B) referred patients
with more than one condition (82.2%). The youngest age group (18 to 44 years) was mostly
referred due to overweight (84%) and was diagnosed with one or two conditions only (88%).
Patients from 45 to 64 years were referred due to respiratory diseases, mental ill-health,
and other reasons in a greater proportion than other age groups. Almost one-third (31.1%)
of older adults (65 years and above) were diagnosed with a cardiovascular condition, while
the percentage in other age groups was below 10%. Participants reporting lower levels of
PA were generally referred with more than one health condition, and the sufficiently active
were referred with a lower number of conditions (see Table 2).
3.2. Effects
Complete collection of clinical parameters was obtained from 43 participants (24%),
and 29 (16%) including HRQOL. Table 3 shows descriptive statistics for baseline clinical
parameters, HRQOL and healthcare attendance among groups. Participant characteristics
did not differ significantly when comparing two subgroups in relation to their basal
PA behaviour. Although overweight participants were the majority in most groups, the
AD-AC group (adhered and previously active) statistically showed a lower proportion
(χ2 = 16.3, p = 0.001) of overweight participants than other groups. The most common
profile for participants in all groups was a woman aged 45–64 being referred by her nurse.
Due to a low sample for four measurements, basal (M1) and post-intervention intention-
to-treat follow-up (MOT3) were chosen for pre-post analyses and grouping adhered partic-
ipants and non-adhered participants. Thus, the adhered group (AD-Group) comprised of
AD-IN and AD-AC and the non-adhered group (NA-Group) comprised of NA-AC and
NA-IN. Homogeneity between these two groups was calculated by contrast coefficient
tests not assuming equal variances for age (t = 1.552, p = 0.126) and assuming them for BMI
(t = 0.731, p = 0.466). As a result, adhered and non-adhered groups were homogeneous
at baseline for all clinical parameters, as well as for categorical variables except those
diagnosed with dyslipidaemia and overweight (see Table 4).
There were no statistical differences between the two groups on baseline data, neither
for continuous variables nor for qualitative data (gender, practitioner referring, PHC centre)
except those diagnosed with dyslipidaemia or overweight.
Comparative analyses within and between groups were done using ANOVA for
variables following normal distribution, which resulted to be: resting heart rate, total blood
cholesterol, and LDL-cholesterol. Non-parametric tests were applied for variables that
were not normally distributed: body mass index, waist circumference, systolic and diastolic
blood pressure, triglycerides, HDL-cholesterol, glucose, and glycated haemoglobin.
As shown in Table 5, most clinical parameters improved over time for both groups:
participants who adhered and who did not adhere. Improvements in total blood cholesterol
(p = 0.008, 85% CI [4.3, 26.9]) and BMI (p = 0.013) were found over time regardless of
grouping. Adhered participants saw a significant decrease in their triglycerides level
(28.77%, p = 0.009) when comparing means range. The NA-Group showed significant
improvements in total blood cholesterol (11.71%, p = 0.001, 95% CI [9.7, 36.9]). The range
mean for BMI also improved significantly for the NA-Group (1.91%, p = 0.002); although it
did not for the AD-Group, most likely due to a larger sample. Differences in range mean
for systolic blood pressure were also significant for the NA-Group (3.50%, p = 0.019) while
it did not improve for the AD-Group.
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Table 2. Participants grouping and reasons for prescription.
GENDER PRACTITIONER SETTING AGE GROUP BASAL PA LEVEL a TOTAL

























Reasons for prescriptions b
Overweight
23 (36.5) 67 (58.3) 17 (56.7) 73 (49.9) 37 (48.1) 53 (52.5) 21 (84.0) 41 (44.6) 28 (45.9) 54 (59.3) 36 (41.9) 90 (50.6)
Hypertension
31 (49.2) 49 (42.6) 9 (3.0) 71 (48.0) 26 (33.8) 54 (53.5) 3 (12.0) 43 (46.7) 34 (55.7) 39 (42.9) 40 (46.5) 80 (44.9)
Dyslipidemia
27 (42.9) 37 (32.2) 10 (33.3) 54 (36.5) 22 (28.6) 42 (41.6) 8 (32.0) 35 (38.0) 21 (34.4) 33 (36.3) 31 (36.0) 64 (36.0)
Diabetes Mellitus
29 (46.0) 28 (24.3) 3 (10.0) 54 (36.5) 17 (22.1) 40 (39.6) 2 (8.0) 33 (35.9) 22 (36.1) 30 (33.0) 27 (31.4) 57 (32.0)
Musculoskeletal
5 (7.9) 34 (29.6) 10 (33.3) 29 (19.6) 14 (18.2) 25 (24.8) 3 (12.0) 19 (20.7) 17 (27.9) 22 (24.2) 17 (19.8) 39 (21.9)
Cardiovascular
17 (27.0) 13 (11.3) 5 (16.7) 25 (16.9) 9 (11.7) 21 (20.8) 2 (8.0) 9 (9.8) 19 (31.1) 16 (17.6) 14 (16.3) 30 (16.9)
Respiratory
15 (23.8) 9 (7.8) 5 (16.7) 19 (12.8) 6 (7.8) 18 (17.8) 1 (4.0) 17 (18.5) 6 (9.8) 11 (12.1) 13 (15.1) 24 (13.5)
Mental illness
2 (3.2) 17 (14.8) 5 (16.7) 14 (9.5) 7 (9.1) 12 (11.9) 1 (4.0) 12 (13.0) 6 (9.8) 11 (12.1) 8 (9.3) 19 (10.7)
Other
5 (7.9) 8 (7.0) 2 (6.7) 11 (7.4) 4 (5.2) 9 (8.9) 1 (4.0) 10 (10.9) 2 (3.3) 8 (8.8) 5 (5.8) 13 (7.3)
Number of health conditions
1 16 (25.4) 37 (32.2) 9 (30.0) 44 (29.7) 35 (45.4) 18 (17.8) 11 (44.0) 27 (29.3) 15 (24.6) 24 (26.3) 28 (32.5) 53 (29.8)
2 17 (27.0) 34 (29.6) 11 (36.7) 40 (27.0) 24 (31.2) 27 (26.7) 11 (44.0) 25 (27.2) 51 (28.7) 25 (27.5) 26 (30.2) 51 (28.7)
3 18 (28.6) 28 (24.3) 7 (23.3) 39 (26.4) 13 (16.9) 33 (32.7) 3 (12.0) 26 (28.3) 46 (25.8) 26 (28.6) 20 (23.3) 46 (25.8)
4+ 12 (19.0) 16 (13.9) 3 (10.0) 25 (16.9) 5 (6.5) 23 (22.8) 0 (0.0) 14 (15.2) 28 (15.7) 16 (17.6) 12 (14.0) 28 (15.7)
Note. PA = physical activity; Insuffic. = Insufficient. Bold: the most common condition. a One missing. b The total sums exceed 100%.
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(n = 76) p-value
M SD M SD M SD M SD
Age * 56.0 9.2 64.5 6.5 59.1 13.1 55.8 12.6 0.029
Clinical parameters
BMI (kg/m2) * 32.5 4.2 30.2 4.3 30.9 4.3 33.2 5.2 0.021
Waist circumference (cm) 111.4 15.3 102.3 8.0 105.7 11.4 106.0 9.8 0.487
Systolic blood pressure (mmHg) 131.1 11.2 140.3 15.3 134.3 17.0 134.2 15.7 0.385
Diastolic blood pressure (mmHg) 79.2 8.6 77.1 7.4 77.6 11.0 79.8 10.8 0.575
Resting heart rate (beats/min) 74.0 14.1 75.2 15.8 73.0 12.5 77.0 11.5 0.552
Total blood cholesterol (mg/dl) 201.9 26.8 203.8 40.5 202.7 41.5 207.5 38.9 0.923
LDL blood cholesterol (mg/dl) 125.5 23.1 121.5 34.4 120.2 35.8 122.2 32.6 0.974
Triglyceride (mg/dl) 144.2 69.8 155.4 88.5 155.5 94.3 153.9 70.6 0.979
HDL blood cholesterol (mg/dl) 60.4 19.7 51.3 13.2 52.4 14.2 53.5 13.0 0.423
Plasma glucose (mg/dl) 115.2 33.5 114.5 25.5 116.9 42.8 118.9 38.9 0.970
Glycated haemoglobin (%) b 7.5 1.5 7.1 0.9 7.7 1.4 7.4 1.2 0.693
SF-12v2 questionnaire outcomes
Physical functioning 44.7 8.0 54.5 4.5 45.6 7.5 45.1 9.0 0.184
Role physical 46.1 5.3 57.4 4.7 46.0 10.4 44.2 12.8 0.161
Bodily pain 33.4 5.9 25.3 4.6 33.7 11.6 36.4 12.9 0.272
General health 40.4 5.5 48.2 9.9 40.9 6.9 40.1 8.1 0.237
Vitality 46.0 11.3 54.2 21.0 52.9 11.6 51.3 13.8 0.547
Social functioning 41.2 9.8 51.8 10.6 46.8 12.4 44.6 12.9 0.448
Mental health 45.5 10.7 53.9 8.4 45.4 11.8 42.5 12.4 0.251
Role emotional 50.3 13.5 47.2 10.6 49.2 11.8 50.1 12.7 0.954
PCS: Summary scale Physical 39.3 5.5 45.1 2.2 39.5 6.1 39.7 6.2 0.353
MCS: Summary scale Mental 48.4 14.0 53.5 9.3 51.2 13.3 49.4 15.3 0.871
Health-care attendance
In the year prior to inclusion (visits per month) 1.1 0.6 1.5 0.9 1.6 1.2 1.5 1.2 0.574
Note. AD-IN = adhered and previously inactive, AD-AC = adhered and previously active, NA-AC = non adhered and previously active,
NA-IN = non adhered and previously inactive, BMI = body mass index. * p < 0.05. a 1 missing. b Sample size for participants diagnosed
with diabetes mellitus: Total (n = 57), AD-IN (n = 6), AD-AC (n = 9), NA-AC (n = 18), NA-IN (n = 24).





(n = 142) p-value
M SD M SD
Age 60.8 8.8 57.4 12.9 0.126
Clinical parameters
BMI (kg/m2) 31.2 4.3 32.2 4.9 0.466
GROUPS
AD-Group NA-Group p-value
n = 35 (%) n = 142 (%)
Diagnosed dyslipidaemia 19 (29.7) 45 (70.3) 0.022 *,a
Diagnosed overweight 12 (13.3) 78 (86.7) 0.046 *,b
Note. AD-Group = adhered, NA-Group = non-adhered, BMI = body mass index, kg = kilogram, m = metre. a Continuity correction = 5.270.
b Continuity correction = 3.998. * p < 0.05.
After the intervention all participants answered feeling equal or better than the in-
clusion day. None of the respondents reported feeling worse compared to their first day
and 100% of previously inactive participants reported feeling better than their first day. No
participants (n = 0) reported any health problem due to the exercise prescriptions.
Participant health-care attendance was similar before, during, and after the CAMINEM
intervention. Globally, participants averaged 1.5 visits per month in the year before their
inclusion. Participants who finally adhered averaged 1.3 visits to their health practitioner
during the time the CAMINEM was delivered, less than participants who did not adhere
(1.5), although these differences were not statistically significant (p > 0.05). See Figure 2.
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3.3. Adoption
A total of 82 health practitioners were invited to refer patients and none of them
for ally refused to participate, although 49 (60%) did not refer any patients throughout
the 18-month intervention. Three patients registered at other primary health-care settings
prompted their GP to be referred, and were finally included. Nurses referred 186 (81%)
patients and GPs referred 43 (19%). Ten practitioners referred more than ten patients while
another ten referred only one. No supply physicians referred patients, whereas nurses
referred patients regardless of their employment situation: eight out of twelve substitute
nurses referred (66.67%) and 19 out of 34 regular nurses (55.88%) did.
3.4. Implementation
Thirty-five participants (19.66%) adhered for more than 180 days. Twelve other
participants were retained for more than six months without being compliant. Almost
half of non-adhered participants (42.3%) followed the exercise prescription before dropout.
Table 6 shows the distribution of adherence of the four groups. Adhered participants
were of similar age compared to the non-adhered, although the AD-AC group was the
oldest, with a mean value over 64 years and 95% CI [61.38, 67.52]. Ninety-eight participants
(56.60%) dropped out within the first three months. The main reasons for dropping out
were not attending three consecutive meetings or not answering three phone calls.
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Table 5. Intention-to-treat multivariate analyses of variance
Measure M1 MOT3 Signification effects Evolution
Group AD (n = 35) NA (n = 142) AD (n = 23) NA (n = 110) Group Time AD NA
HR a
(beats/min)
M 72.9 73.6 72.7 76.2 0.21% −3.50%
SD 15.8 12.1 15.7 13.4 p = 0.583 p = 0.564 p = 0.969 p = 0.271
n 14 32 14 32 Mdif = 2.1 Mdif = 1.3 Mdif = 0.1 Mdif = 2.7
CHO a
(mg/dl)
M 201.2 222.3 193.4 199.0 4.06% 11.71%
SD 25.4 43.3 36.4 41.8 p = 0.287 p = 0.008** p = 0.383 p = 0.001 **
n 13 23 13 23 Mdif = 13.3 Mdif = 15.6 95% CI [4.3, 26.9] Mdif = 7.8 Mdif = 23.3
95% CI [9.7, 36.9]
LDL a
(mg/dl)
M 125.8 127.7 127.7 115.1 −1.48% 10.95%
SD 22.2 35.0 40.4 38.4 p = 0.698 p = 0.413 p = 0.852 p = 0.131
n 9 14 9 14 Mdif = 5.4 Mdif = 5.4 Mdif = 1.9 Mdif = 12.6
M 30.5 33.4 29.9 32.8 M1 MOT3 1.99% 1.91%
SD 4.1 4.6 4.0 4.4 U = 1553.0 U = 242.0 Z = 1.862 Z = 3.314BMI
b
(kg/m2)
n 18 44 18 44 p = 0.230 p = 0.013 * p = 0.063 p = 0.002 **
M 102.6 108.7 100.6 106.75 M1 MOT3 1.99% 1.87%
SD 9.09 12.3 7.2 11.3 U = 441.5 U = 75.0 Z = 0.847 Z = 1.791WC
b
(cm)
n 7 8 7 8 p = 0.995 p = 0.521 p = 0.397 p = 0.073
M 137.5 135.3 138.6 130.8 M1 MOT3 −0.76% 3.50%
SD 15.6 15.9 16.9 14.6 U = 1775.0 U = 375.0 Z = 0.207 Z = 2.349SBP
b
(mmHg)
n 17 51 17 51 p = 0.303 p = 0.124 p = 0.836 p = 0.019 *
M 76.8 80.4 76.2 79.4 M1 MOT3 0.76% 1.31%
SD 6.9 11.1 9.1 10.3 U = 1943.0 U = 385.5 Z = 0.649 Z = 0.791DBP
b
(mmHg)
n 17 51 17 51 p = 0.757 p = 0.161 p = 0.516 p = 0.429
M 144.9 171.2 112.5 145.9 M1 MOT3 28.77% 17.37%
SD 70.9 90.4 43.4 87.8 U = 1482.5 U = 206.5 Z = 2.621 Z = 1.773TG
b
(mg/dl)
n 13 21 13 21 p = 0.736 p = 0.220 p = 0.009 ** p = 0.076
M 51.9 51.2 52.0 50.0 M1 MOT3 −0.21% 2.42%
SD 13.0 12.1 8.5 11.1 U = 1113.5 U = 132.5 Z = 0.178 Z = 0.624HDL
b
(mg/dl)
n 9 14 9 14 p = 0.808 p = 0.864 p = 0.859 p = 0.533
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Table 5. Cont.
Measure M1 MOT3 Signification effects Evolution
Group AD (n =35) NA (n = 142)
AD (n =
23) NA (n = 110) Group Time AD NA
M 114.4 119.1 107.2 113.0 M1 MOT3 6.67% 5.43%
SD 28.9 41.7 23.5 25.3 U = 1701.0 U = 243.5 Z = 0.754 Z = 0.505GLY
b
(mg/dl)
n 14 21 14 21 p = 0.983 p = 0.448 p = 0.451 p = 0.614
M 7.4 7.4 7.2 7.2 M1 MOT3 2.58% 1.77%
SD 1.4 0.9 1.0 1.1 U = 214.5 U = 33.5 Z = 0.406 Z = 0.254HbA1c
b,c
(%)
n 7 7 7 7 p = 0.565 p = 0.565 p = 0.684 p = 0.799
Note. M1 = basal, MOT3 = over time post-intervention, AD = adhered to the intervention, NA = non adhered to the intervention, HR = heart rate, min = minute, Mdif = mean difference, CHO = total cholesterol,
mg = milligram, dl = decilitre, CI = confidence interval, BMI = body mass index, kg = kilogram, m = metre, WC = waist circumference, cm = centimetre, SBP = systolic blood pressure, mmHg = millimetres of
mercury, DBP = diastolic blood pressure, TG = triglyceride, GLY = fasting glucose. a 2 × 2 multivariate analysis. Age-adjusted comparison. b Mann-Whitney U (pre- and post-intervention) and Wilcoxon’s Z (pre-
and post-intervention within group). c Percentage varies due to decimals. * p < 0.05 ** p < 0.01.
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Table 6. Distribution of CAMINEM adherence by intervention groups.
ATTENDANCE RETENTION COMPLIANCE




GROUP n = 66 (%) n = 111 (%) n = 130 (%) n = 47 (%) n = 82 (%) n = 95 (%) n = 177 (%)
AD-IN 0 (0) 15 (100) 0 (0) 15 (100) 0 (0) 15 (100) 15 (100)
AD-AC 0 (0) 20 (100) 0 (0) 20 (100) 0 (0) 20 (100) 20 (100)
NA-AC 27 (40.9) 39 (59.1) 61 (92.4) 5 (7.6) 34 (51.5) 32 (48.5) 66 (100)
NA-IN 39 (51.3) 37 (48.7) 69 (90.8) 7 (9.2) 48 (63.2) 28 (36.8) 76 (100)
Note. ExRx = exercise prescription, AD-IN = adhered and previously inactive, AD-AC = adhered and previously active, NA-AC, not
adhered and previously active, NA-IN = not adhered and previously inactive. a 1 missing.
4. Discussion
This study was, to our knowledge, the first pragmatic study assessing the feasibility
of an exercise prescription intervention in primary health-care settings based on matching
exercise training principles and public health promotion. The feasibility of pragmatic
interventions intends to answer the recommended evaluative questions suggested by
Estabrooks & Gyurcsik across the RE-AIM dimensions [37]. The “efficacy/effectiveness”
dimension was substituted by the “effects” due to lack of a previously efficacy trial (i.e.,
under optimal conditions).
The overall aim of this pragmatic study was to evaluate the feasibility (i.e., external
validity) of the CAMINEM (Let’s Walk) Programme as an exercise-on-prescription, inter-
disciplinary approach for 12 months in two socially disadvantaged neighbourhoods. The
specific aims were to (i) determine if the CAMINEM reached the citizens with chronic health
conditions that may benefit from exercising (Reach), (ii) assess clinical and quality-of-life
outcomes and the use of health services (Effects), (iii) determine the adoption of CAMINEM
by the practitioners (Adoption), (iv) evaluate participants’ retention and compliance (Im-
plementation), and (v) describe if the practitioners prescribe exercise post-intervention
(Maintenance). As stated previously, maintenance could not be finally evaluated due to a
low sample for data collection.
4.1. Did the CAMINEM Programme Reach the Target Population?
The results flagged up 16,744 patients who fulfilled the inclusion criteria, of which
15,374 (91.82%) had visited their health practitioner at least once during the intervention.
The proportion is slightly higher than the average of 87% of Spanish citizens who visited
their practitioners in 2005 [38], and similar to 94% of citizens who lived in the same
region where the study was implemented, based on self-reported data from 2018–2019 [39].
Selected nurses volunteered to record the number of patients who were invited, and who
did not wish to take part in the study. However, they did not report any data. They were
reminded several times but eventually the research group decided not to insist due to
practitioners’ time constraints. If we could analyse the number of withdrawals at this
stage, then we may drive the intervention to: more stress on behaviour counselling (if
high number of patients refusing) or more emphasis on recruitment (if low number of
invitations). The lack of a concrete number of target participants refusing to take part in
the physical activity referral intervention was also reported in the EXERT study [40]. In
contrast to the EXERT, all referrals (n = 229) reached the exercise physiologist, which is
the 1.49% of the eligible population (N = 15,374). Of referrals, 28 (12.23%) patients did not
attend the first counselling meeting and the final number of included participants was 178,
1.16% of the eligible population.
A similar proportion is reported in other studies. Of all participants referred by a
health professional, 27% never made contact with the exercise referral scheme in a British
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study [41]. More recently, data of seven years of the Welsh referral programme showed a
reach of 3.3% of the population [42], which is an average of roughly 0.7% each 18 months,
the length of the CAMINEM study. In Sweden, the FaR® scheme reached 1.5% of the total
population, and 1.3% of those who attended their primary health-care setting [43]. Less
than 1% was reported in a revision in the UK [44]. More intensive interventions reached
a higher proportion of the target population. One intervention in Switzerland aimed at
increasing physical activity in inactive regular patients invited all patients attending five
volunteer GP for an RCT [45]. The practitioners were reimbursed with 25 CHF (€18) for
each questionnaire that was filled out in their office. The Newcastle exercise project reached
17% for their RCT, but the researcher was in the practice to initiate recruitment daily [46].
In sum, 1.16% of the eligible population reached the programme which is a similar
proportion to other physical activity prescription intervention studies.
4.2. What Were the Effects of the CAMINEM PROGRAMME?
Clinical health and quality-of-life outcomes for adhered participants followed positive
patterns, although few were statistically significant. From a pragmatic point of view,
note that non-adhered participants visited their practitioner more compared to adhered
participants. Also, none of the participants reported any injury or complication of their
disease due to the exercise participation, which let us confirm that the intervention was
safe even without supervision by exercise professionals. This programme followed global
and regional recommendations on health-enhancing physical activity [1,15,24,27] and its
results could be useful for future interventions. A systematic review of exercise referral
schemes did not find consistent evidence in favour of the interventions in outcomes based
on health-related quality of life, blood pressure, serum lipid levels, indices of obesity, or
glycemic control, among others [47].
Despite the aforementioned, every increase in physical activity, even small, entails
health gains at both an individual level and public health level regardless of whether they
reach the recommendations of physical activity levels [6,48].
4.3. Was the CAMINEM Programme Adopted by the Health Practitioners?
None of the practitioners formally refused to participate and nurses referred four
times more than physicians (81% and 19% respectively). One GP and one community
nurse form the primary health-care unit patients can visit. Nurses were more engaged
in the intervention. However, nurses were in charge of collecting the clinical data at
baseline, during and after the intervention but they did not collect as it was agreed due
to time constraints. Regular referral by the 18-month timeframe of the implementation
suggests that the CAMINEM procedures facilitated the Catalan practitioners to cope with
the barriers for HEPA promotion [14].
4.4. Could the CAMINEM Programme Be Implemented the Way It Was Designed?
Our challenge was to monitor exercise prescription adherence and collect reported
data from the participants to adapt new exercise prescriptions following individualised
progressions to achieve greater benefits. Adhered and non-adhered participants were
completing their prescriptions, so dropouts were due to other reasons rather than challenges
on understanding or following the prescriptions. Adherence to the walking intervention
showed no relation to age or diagnose. Probably the type of exercise prescribed, walking,
was not encouraging enough for some individuals and future interventions may include
other types of physical activity (e.g., cycling, swimming, callisthenics), individually or
as group-based activities (e.g., dancing, team sports, instruction-led group exercise), to
improve aerobic and other physical capacities (e.g., strength, flexibility).
The CAMINEM Programme tools [22,26] were implemented and interdisciplinary
work was achieved in the real setting, as previous experiences pointed out as a main
challenge to cope with, such as lack of time, training and protocols [10,11,14,49]. Follow-up
of the exercise prescriptions was possible using the CAMINEM Programme tools.
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The CAMINEM procedures for implementation have been the framework to adapt in
Catalonia the Swedish Physical Activity on Prescription model (FaR, in Swedish) under a
3rd Health Programme grant by the European Commission [50].
4.5. Study Limitations
The CAMINEM practice-driven, rather than research-driven, procedures resulted
in poor data collection. In the eighteen-month intervention period, the recruitment of
patients was the responsibility of health practitioners and was undertaken during their
regular consultations. Adoption of the programme relied on practitioners who were
motivated to participate during their regular practice, even though they did not have formal
recommendations from the healthcare provider. This resulted in a relatively low number of
referrals and a high proportion of missing data related to clinical health outcomes, which
limited the impact of the clinical results. Perhaps tighter control on data collection and
referral procedures co-ordinated by the steering group may have shown more positive
outcomes. Organisational instructions by decision-makers may have encouraged motivated
practitioners and served as a guarantee for some practitioners who did not refer patients or
only referred a few.
Both primary health-care settings are located in socially deprived neighbourhoods
and some practitioners reported that health promotion interventions are rarely adopted by
some ethnic minorities. The overall intervention was strongly associated with the personal
interest of all agents involved, which had to cope with the political and financial situation
which led to structural changes in the public administration (both Catalan and Spanish)
in general and health-care administration in particular, such as, staff layoffs or budget
reduction, among other organisational issues.
4.6. Practical Implications
• This study assessed tools and procedures to encourage practitioners during their
regular consultations to prescribe exercise to cope with the most prevalent chronic
diseases.
• Regular practitioners had severe time constraints to strictly collect relevant health
data to monitor the effects of the exercise prescriptions.
• The procedures to prescribe exercise were easy to understand and complete by the
participants, easy to deliver, to monitor and to adapt by the exercise physiologists.
• The intervention framework may provide practice-based evidence to adapt exercise-
on-prescriptions approaches in real settings to achieve public health goals.
5. Conclusions
The overall goal of this study was to evaluate the applicability of an exercise-on-
prescription intervention in primary health-care settings: the CAMINEM Programme.
CAMINEM used an interdisciplinary approach comprised of primary health-care practi-
tioners (general practitioners and nurses) and exercise physiologists. The intervention was
carried out with the underlying aim of improving regular patients’ health by facilitating
the adoption and maintenance of exercise levels with safe, home-based exercises (walk-
ing). Two separate study objects provided the focus for this study. First, regular patients,
with chronic health conditions that may benefit from exercise, that attended their primary
health-care centre were assessed for intervention effects. On the other hand, both patients
and health practitioners (i.e., general practitioners and nurses) were to be evaluated for
intervention feasibility.
The CAMINEM Programme has been found to be feasible in real practice. Exercise
prescriptions were for moderate-intensity aerobic activity in the form of walking outdoors
following specific urban routes. It reached the target population, it was adopted by health
practitioners, and it was implemented following the procedures. Health outcomes were
positive although few clinical effects showed statistically significant differences. Health-
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related quality-of-life of adhered participants improved and they were less likely to visit
their GP or nurse.
Future research-oriented initiatives may target selected health practitioners to collect
all data or include an external researcher with this responsibility and use objective measures
for physical activity levels, sedentary behaviour, and health-related fitness evaluation. All
of the beforementioned requires specific funding and may not be feasible in real practice.
On the other hand, future practice-oriented interventions may design specific and safe
procedures to prescribe, monitor, and follow-up home-based exercise to improve other
fitness capacities (e.g., muscle strength, balance, flexibility) or to improve aerobic capacity
by walking or other activities according to the participants’ preferences or accessibility.
Selection of feasible fitness tests to apply in real practice may also be of interest.
Supplementary Materials: The following are available online at https://www.mdpi.com/1660-4
601/18/6/3192/s1, Figure S1: CAMINEM Referral procedure, Figure S2: CAMINEM First contact
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Table S5: Criteria to determine exercise prescription progression.
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20. Mas-Alòs, S.; Aleknavičius, K.; Avelar Rosa, B.; Banzer, W.; Borg Buontempo, M.; Carraro, N.; Clausen, M.M.; Demeyer, D.;
Domnariu, C.; Farías-Torbidoni, E.I.; et al. EUPAP Feasibility Study. Final Report; Mas-Alòs, S., Ed.; Institut Nacional d’Educació
Física de Catalunya, Departament de Presidència, Generalitat de Catalunya: Lleida, Catalonia, 2020; ISBN 978-84-18199-33-2.
21. Kallings, L.V. Physical Activity on Prescription. In Studies on Physical Activity Level, Adherence and Cardiovascular Risk Factors;
Karolinska Institutet: Stockholm, Sweden, 2008.
22. Mas Alòs, S.; Galindo Ortego, G.; Planas Anzano, A.; Peirau Terés, X.; Real, J. Health promotion and exercise prescription in
primary health-care settings—Rationale and design of the Let’s Walk Program (CAMINEM). Apunts. Educ. Fís. Deporte 2017, 130,
40–57. [CrossRef]
23. Mas Alòs, S. Exercise on Prescription and Exercise Planning in Primary Health-Care Settings an Approach By the ‘Let’S Walk Programme’
(Programa Caminem); University of Lleida: Lleida, Catalonia, Spain, 2012.
24. Departament de Salut, Generalitat de Catalunya. Pla de Salut de Catalunya a L’horitzó 2010: Els 5 Eixos Estratègics que Articulen les
Polítiques de Salut. 2a Part; Departament de Salut, Generalitat de Catalunya, Ed.; Departament de Salut: Barcelona, Spain, 2009;
Volume II.
25. World Health Organization Thirty-Year Retrospective of Catalan Health Planning; WHO Regional Office for Europe: Copenhagen,
Denmark, 2020.
26. Planas, A.; Peirau, X.; Pujol, J.; Farreny, D. Validation of Urban Itineraries for the Prescription of Physical Exercise. Apunts. Educ.
Fís. Deporte 2010, 100, 12–20.
27. Departament de Salut, Generalitat de Catalunya. Guia de Prescripció de L’exercici Físic per a la Salut (PEFS); Vallbona Calbó, C.,
Roure Cuspinera, E., Violan Fors, M., Peirau Terés, X., González Peris, M., Eds.; Direcció General de Salut Pública, Secretaria
General de l’Esport: Barcelona, Spain, 2007.
28. Aittasalo, M.; Miilunpalo, S.; Kukkonen-Harjula, K.; Pasanen, M. A randomized intervention of physical activity promotion and
patient self-monitoring in primary health care. Prev. Med. 2006, 42, 40–46. [CrossRef]
29. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 9th ed.; Thompson, W.R., Gordon,
N.F., Pescatello, L.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2010; ISBN1 9780781745062. ISBN2 0781745063.
30. Foster, C.; Porcari, J.P.; Anderson, J.; Paulson, M.; Smaczny, D.; Webber, H.; Doberstein, S.T.; Udermann, B. The talk test as a
marker of exercise training intensity. J. Cardiopulm. Rehabil. Prev. 2008, 28, 24. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 3192 18 of 18
31. Freene, N.; Waddington, G.; Chesworth, W.; Davey, R.; Cochrane, T. Validating two self-report physical activity measures in
middle-aged adults completing a group exercise or home-based physical activity program. J. Sci. Med. Sport 2014, 17, 611–616.
[CrossRef]
32. Glasgow, R.E. Evaluation of theory-based interventions. The RE-AIM Model. In Health Behavior and Health Education: Theory,
Research, and Practice; Glanz, K., Rimer, B.K., Lewis, F.M., Eds.; Jossey-Bass: San Francisco, CA, USA, 2002; pp. 530–544. ISBN
0-7879-5715-1.
33. Estabrooks, P.A.; Gyurcsik, N.C. Evaluating the impact of behavioral interventions that target physical activity: Issues of
generalizability and public health. Psychol. Sport Exerc. 2003, 4, 41–55. [CrossRef]
34. Vilagut, G.; Valderas, J.M.; Ferrer, M.; Garin, O.; Lopez-Garcia, E.; Alonso, J. Interpretation of SF-36 and SF-12 questionnaires in
Spain: Physi.cal and mental components. Med Clin. 2008, 130, 726–735. [CrossRef] [PubMed]
35. Aittasalo, M.; Miilunpalo, S.; Kannas, L.; Laitakari, J.; Bull, F.; van Poppel, M.; Bauman, A. Promoting Physical Activity of
Working Aged Adults with Selected Personal Approaches in Primary Health Care. In Feasibility, Effectiveness and an Example of
Nationwide Dissemination; University of Jyväskylä: Jyväskylä, Finland, 2008.
36. Robison, J.I.; Rogers, M.A. Adherence to exercise programmes. Recommendations. Sport Med. 1994, 17, 39–52. [CrossRef]
37. Estabrooks, P.A.; Glasgow, R.E. Translating Effective Clinic-Based Physical Activity Interventions into Practice. Am. J. Prev. Med.
2006, 31, 45–56. [CrossRef]
38. Ministerio de Sanidad y Consumo Encuesta Nacional de Salud de España. Available online: http://www.ine.es (accessed on 1
February 2021).
39. Departament de Salut. Generalitat de Catalunya Enquesta de Salut de Catalunya (ESCA). Available online: https://salutweb.
gencat.cat/ca/el_departament/estadistiques_sanitaries/enquestes/esca/resultats_enquesta_salut_catalunya/ (accessed on 1
February 2021).
40. Isaacs, A.J.; Critchley, J.A.; See Tai, S.; Buckingham, K.; Westley, D.; Harridge, S.D.R.; Smith, C.; Gottlieb, J.M. Exercise Evaluation
Randomised Trial (EXERT): A randomised trial comparing GP referral for leisure centre-based exercise, community-based
walking and advice only. Health Technol. Assess 2007, 11, 1–165. [CrossRef] [PubMed]
41. Dugdill, L.; Graham, R.C.; McNair, F. Exercise referral: The public health panacea for physical activity promotion? A critical
perspective of exercise referral schemes; their development and evaluation. Ergonomics 2005, 48, 1390–1410. [CrossRef]
42. Morgan, K.; Rahman, M.; Moore, G. Patterning in Patient Referral to and Uptake of a National Exercise Referral Scheme (NERS)
in Wales from 2008 to 2017: A Data Linkage Study. Int. J. Environ. Res. Public Health 2020, 17, 3942. [CrossRef] [PubMed]
43. Leijon, M.E.; Bendtsen, P.; Nilsen, P.; Ekberg, K.; Ståhle, A. Physical activity referrals in Swedish primary health care—Prescriber
and patient characteristics, reasons for prescriptions, and prescribed activities. BMC Health Serv Res 2008, 8, 201. [CrossRef]
44. Fox, K.; Biddle, S.; Edmunds, L.; Bowler, I.; Killoran, A. Physical activity promotion through primary health care in England. Br. J.
Gen. Pract. 1997, 47, 367–369.
45. Jimmy, G.; Martin, B.W. Implementation and effectiveness of a primary care based physical activity counselling scheme. Patient
Educ. Couns. 2005, 56, 323–331. [CrossRef]
46. Harland, J.; White, M.; Drinkwater, C.; Chinn, D.; Farr, L.; Howel, D. The Newcastle exercise project: A randomised controlled
trial of methods to promote physical activity in primary care. Br. Med. J. 1999, 319, 828–832. [CrossRef]
47. Pavey, T.G.; Taylor, A.H.; Fox, K.R.; Hillsdon, M.; Anokye, N.; Campbell, J.L.; Foster, C.; Green, C.; Moxham, T.; Mutrie, N.; et al.
Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: Systematic review and
meta-analysis. BMJ 2011, 343, 6462. [CrossRef] [PubMed]
48. Kallings, L.V.; Leijon, M.E.; Kowalski, J.; Hellénius, M.-L.; Ståhle, A. Self-reported adherence: A method for evaluating prescribed
physical activity in primary health care patients. J. Phys. Act. Health 2009, 6, 483–492. [CrossRef] [PubMed]
49. Petrella, R.J.; Lattanzio, C.N.; Overend, T.J. Physical Activity Counseling and Prescription Among Canadian Primary Care
Physicians. Arch. Intern. Med. 2007, 167, 1774–1781. [CrossRef] [PubMed]
50. EUPAP Consortium EUPAP—A European Physical Activity on Prescription Model. Available online: www.eupap.org (accessed
on 1 February 2021).
